Clinical trial
Impact of Hepatitis C Therapy and Bone Health
NCT03221582
Study timeline
Study start (actual)2017-08-28Date precision: day
Registry last updated2019-08-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Human Immunodeficiency Virusunresolved
Hepatitis Cunresolved
Interventions
EBR/GZRDRUG
Sponsors & collaborators
Dallas VA Medical Centerlead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03221582 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.